Spots Global Cancer Trial Database for endometrial endometrioid adenocarcinoma

Every month we try and update this database with for endometrial endometrioid adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer	NCT04214067	Endometrial End... Stage I Uterine... Stage II Uterin...	Biospecimen Col... Brachytherapy Computed Tomogr... External Beam R... Magnetic Resona... Pembrolizumab Quality-of-Life... Questionnaire A... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
AMT-151 in Patients With Selected Advanced Solid Tumours	NCT05498597	Advanced Solid ... Advanced Cancer Advanced Carcin... Ovarian Cancer Ovarian Carcino... Ovarian Epithel... Ovarian Endomet... Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial End... Endometrial Cle... Lung Adenocarci... Triple Negative... Pancreatic Duct... Malignant Pleur... Ovarian Clear C... Ovarian Clear C... Ovarian Mucinou...	AMT-151	18 Years -	Multitude Therapeutics Inc.
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	NCT05950464	Endometrial Car... Endometrial Cle... Endometrial End... Endometrial Low... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Low Gra... Platinum-Resist...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Electrocardiogr... Magnetic Resona... Tuvusertib X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer	NCT03422198	Endometrial Cle... Endometrial End... Endometrial Ser... Stage I Uterine... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Uterine Corpus ... Uterine Corpus ...	Vaginal Cuff Br... Short course va...	-	University of Utah
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT00478426	Endometrial Ade... Endometrial End... Endometrial Ser... Recurrent Uteri... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	NCT03914612	Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Recurrent Endom... Stage III Uteri... Stage IV Uterin...	Carboplatin Computed Tomogr... Paclitaxel Pembrolizumab Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer	NCT04049227	Endometrial End...	Abemaciclib Letrozole Therapeutic Con...	18 Years -	Northwestern University
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer	NCT04214067	Endometrial End... Stage I Uterine... Stage II Uterin...	Biospecimen Col... Brachytherapy Computed Tomogr... External Beam R... Magnetic Resona... Pembrolizumab Quality-of-Life... Questionnaire A... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer	NCT04972682	Endometrial Can... Endometrial Neo... Endometrial Ade... Endometrial Can... Endometrial Can... Endometrial End... Sentinel Lymph ... Hysterectomy Laparoscopic Hy...	Laparoscopic to...	18 Years -	Moscow City Oncology Hospital No. 62
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma	NCT05112601	Endometrial Ade... Endometrial Cle... Endometrial Ded... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Und... Endometrioid Ad... Recurrent Endom...	Biospecimen Col... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	NCT02020707	Cervical Adenoc... Cervical Adenos... Cervical Adenos... Cervical Carcin... Cervical Squamo... Clinical Stage ... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Und... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Malignant Femal... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Perit... Malignant Solid... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Mucinou... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Sensit... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Unresectable Me... Uterine Corpus ...	Bevacizumab Laboratory Biom... Nab-paclitaxel Pharmacological...	18 Years -	Mayo Clinic
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer	NCT05950464	Endometrial Car... Endometrial Cle... Endometrial End... Endometrial Low... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Low Gra... Platinum-Resist...	BET Bromodomain... Biopsy Biospecimen Col... Computed Tomogr... Electrocardiogr... Magnetic Resona... Tuvusertib X-Ray Imaging	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: